The growing popularity of minimally invasive surgeries among a considerable chunk of the global populace will prove to be a growth booster for the arterial stents market. The expanding number of cases related to artery blockage is propelling the demand for arterial stents to a large extent. Furthermore, the rising incidents of cardiovascular diseases around the world will serve as a growth booster for the arterial stents market.

The COVID-19 pandemic is playing an important role in accelerating the demand for arterial stents. The rising number of the COVID-19 infections around the world is encouraging hospitalizations on a large scale. Furthermore, people having cardiovascular issues may have high severity of the COVID-19 infection. Thus, these factors will have a positive impact on the growth of the arterial stents market.

The benefits associated with stenting procedures will have a prominent effect on the growth of the arterial stents market. Advantages such as damage prevention to blood vessels and extensive improvement in the blood flow will bring immense growth prospects for the arterial stents market. In addition, stenting procedures promote lesser hospital stays. These aspects will attract considerable growth for the global market during the forecast period. Hence, the arterial stents market is experiencing a steady growth across the globe.

R&D activities play a crucial role in the growth of the arterial stents market. Players invest in these activities to boost innovation in the stents and make them more efficient. Furthermore, mergers and acquisitions are also pivotal for the arterial stents market. Companies indulge in strategic collaborations to expand their influence across different regions and increase their production capacities. These aspects bode well for the growth of the arterial stents market.

The arterial stents market is estimated to observe promising growth prospects in Europe. The region is prognosticated to emerge as a dominant growth contributor in the arterial stents market owing to presence of well-established players and the increasing demand for minimally invasive surgeries in Europe.

Growing preference for minimally invasive surgeries (MIS) may prove as a prime reason for the growth of the arterial stents market. An increasing number of patients with more than 70 percent of artery blockage is pushing the arterial stents market toward growth. Arterial stents are in existence since the 1980s. Technological advancements have been taking place in arterial stents over the past few years. The COVD-19 pandemic is proving to be risky for patients with cardiovascular disorders. Therefore, this period can bring good growth opportunities for the arterial stents market.

  • The arterial stents market can be segmented into coronary stents and peripheral stents, by product. Further, coronary stents are sub-divided into the bioresorbable stent, drug-eluting stents, and bare-metal stents. Balloon-expandable stents and self-expandable stents come under peripheral stents.
  • The arterial stents market may shine across the forecast period owing to the factors like concerning rise in hypertension cases and the elderly being more prone to varied cardiovascular diseases resulting from high serum cholesterol levels. In addition, soaring obesity cases are also likely to fuel the arterial stents market toward growth.
  • Stenting procedures also include benefits like prevention of further damage to blood vessels as well as considerable improvement in blood flow. The new coronavirus outbreak has left almost all hospitals overflowing with patients due to the surge in infected patients. Short hospital stays are beneficial for avoiding COVID-19 transmission as well as for prioritizing treatment of infected patients. Stenting procedures lead to shorter hospital stays. Thus, this factor will provide a great opportunity for the arterial stents market to make a mark across the forecast period.
  • Novel product launches like Venovo Venous Stent Systems are further proving to be a boon for the arterial stents market. These new technologies are inviting efficiency and quick treatment of patients, thus benefiting the arterial stents market.

Global Arterial Stents Market: Snapshot

The global arterial stents market is rising due to the increasing prevalence of atherosclerosis and other arterial disorders along with introduction of innovative arterial stents such as bioresorbable stents. Furthermore, efficacy of arterial stents for the treatment of peripheral and coronary artery diseases and preference for minimally invasive procedures to unblock arteries and to improve blood flow are some other key factors driving the arterial stents market.

On the flip side, lack of well-equipped healthcare facilities and lack of well-trained interventional cardiologists in emerging economies are challenging the market’s growth.

A report by Transparency Market Research (TMR), projects the global arterial stents market to expand at a healthy 9.5% CAGR during the forecast period between 2017 and 2025. Progressing at this rate, the market which stood at US$8.0 bn in 2016 will become worth US$17.8 bn by the end of 2025.

arterial stents market

Introduction of New Product Variants Makes Coronary Stents Dominant

The global arterial stents market is studied on the basis of product type, application, and region in this report. On the basis of product type, the arterial stents market is segmented into coronary stents and peripheral stents. The sub-segments of coronary stents include bare metal stents, drug-eluting stents, bioresorbable stents, and others. The others sub-segment within coronary stents include covered stents and dual-therapy stents. The peripheral stents segment is further classified into self-expanding stents, balloon-expanding stents, and others. The others sub-segment within peripheral stents comprise covered stents and drug-eluting stents.

Of them, coronary stents held the leading market share vis-à-vis revenue in 2016, the growth of this segment is attributed to the rising adoption of novel coronary stents such as bioresorbable stents by interventional cardiologists. Drug-eluting stents within coronary stents accounted for the leading revenue generation in 2016, and is likely to hold on to its dominant position over the forecast period. The growth of drug-eluting segment is due to development and incorporation of anti-restenotic agents to prevent the incidence of re-stenosis.

However, peripheral stents is likely to surpass coronary stents in terms of growth rate over the forecast period. This is mainly because of rising awareness of peripheral artery diseases and introduction of innovative stents by key players that are designed for femoral and popliteal arteries.

By application, the global arterial stents market is categorized into coronary artery, iliac artery, carotid artery, femoral and popliteal artery, and others. The others segment comprise below-the knee artery, renal and biliary artery, etc. Of them, coronary artery accounted for the leading revenue contribution in 2016, due to numerous players involved in the manufacture of coronary stents. Going forward, the coronary artery segment is likely to remain dominant until the end of 2025. However, femoral and popliteal artery is likely to display the leading CAGR over the 2017-2025 forecast period; this is owing to clinical research leading to improved access to deep rooted arteries such as femoral and popliteal.

Driven by Modernization of Healthcare Sector in China and India, Asia Pacific to Emerge as Key Market

Geographically, the global arterial stents market is segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Amongst all, in 2016, Europe held the leading market share in terms of revenue; this is mainly due to the strategic presence of key arterial stents manufacturers in Germany and the U.K. The rising preference for minimally invasive surgeries also account for the growth of Europe arterial stents market.

North America ranks as the second-leading market for arterial stents globally, and is likely to expand at a significant CAGR over the 2017-2025 forecast period. However, Asia Pacific is anticipated to display the leading CAGR over the forecast period as large business groups are investing substantially for the modernization of the healthcare sector in China and India.

Leading players operating in the global arterial stents market profiled in the report are Abbott Laboratories, Cordis Corporation, Boston Scientific Corporation, C.R. Bard Inc., Medtronic, Gore Medical, Cook Medical, Biosensors International Group Ltd., Lifetech Scientific, and BIOTRONIK AG.

Global Arterial Stents Market: Overview

Choc-o-bloc with small regional as well as large global players, the global market for arterial stents is highly fragmented. In order to thrive in such a fragmented competitive landscape, big ticket players are seen banking upon effective clinical trials to come up with better products. Despite, involved regulatory approvals, they are charging ahead. A noticeable trend in the market is the usage of nickel titanium alloys and other alloys to build new and better products. Savvy players are also seen collaborating with regulatory agencies in order to further gain a foothold in the market.

Global Arterial Stents Market: Key Trends

Acting as tailwinds to the global market for arterial stents is the rising occurrence of arterial issues, including atherosclerosis. Arterial stents are seeing their popularity grow by the day because of their efficiency in tackling coronary and peripheral artery diseases and also because of the rising knowledge about such minimally invasive methods to open up arteries that carry blood in the human body. Launch of more cutting-edge arterial stents every now and then is proving beneficial for the market too. However, despite so many drivers, the market is being prevented from achieving its full potential because of the dearth of advanced healthcare institutions and highly-skilled interventional cardiologists in developing nations.

The arterial stents being sold in the market can be broadly classified into peripheral stents and coronary stents. The peripheral stents mostly comprise of balloon-expanding stents, self-expanding stents, and others such as drug-eluting stents and covered stents. The coronary stents, on the other hand, consist of bare metal stents, bioresorbable stents, drug-eluting stents, and others such as covered stents and dual-therapy stents. Between coronary and peripheral stents, the former has been grossing most of the revenue on the back of unique products, namely bioresorbable stents highly preferred by interventional cardiologists. Another hit product making significant revenues is drug-eluting stent. Peripheral stents, going forward however, are predicted clock greater growth.

Application-wise, the key segments of the global market for arterial stents market are iliac artery, coronary artery, femoral and popliteal artery, and carotid artery, among others such as renal and biliary artery, below-the knee artery, etc.

Global Arterial Stents Market: Regional Outlook

From a geographical standpoint, Europe accounts for a dominant share in the market for arterial stents mainly because of many prominent manufacturers being domiciled in the nations of the U.K. and Germany. Strong uptake of minimally invasive surgeries in the region has also helped its market. While Europe region takes the lead when it comes to market share, Asia Pacific surpasses others vis-à-vis growth rate. Highly populous, fast expanding economies of China and India, seeing large scale upgrading of their healthcare sector, are mainly said to be powering the growth in Asia Pacific.

Global Arterial Stents Market: Competitive Dynamics

Some of the prominent participants in the global market for arterial stents are Medtronic, Abbott Laboratories, Cordis Corporation, C.R. Bard Inc., Boston Scientific Corporation, Gore Medical, Cook Medical, Lifetech Scientific, Biosensors International Group Ltd., and BIOTRONIK AG.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The report segments the Global Arterial Stents Market into the following:

by Product

  • Coronary Stents
    • Bare Metal Stents
    • Drug-eluting Stents
    • Bioresorbable Stents
    • Others
  • Peripheral Stents
    • Self-expandable Stents
    • Balloon-expandable Stents
    • Others

by Application

  • Coronary Artery
  • Carotid Artery
  • Iliac Artery
  • Femoral & Popliteal Artery
  • Others

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Arterial Stents Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunity
     4.4. Global Arterial Stents Market Analysis and Forecasts, 2015–2025
     4.5. Market Outlook
     4.6. Ker Arterial Diseases: Epidemiology
            4.6.1. Coronary Artery Diseases (CAD)
            4.6.2. Peripheral Artery Diseases (PAD)
     4.7. Arterial Stents: Product Mapping
     4.8. Arterial Stents Market: Key Mergers and Acquisitions
     4.9. Arterial Stents: Global Volume Forecast and Analysis

5. Global Arterial Stents Market Analysis and Forecasts, By Product 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Market Value Forecast By Product, 2015–2025
            5.3.1. Coronary Stents
                     5.3.1.1. Bare Metal Stents
                     5.3.1.2. Drug-eluting Stents
                     5.3.1.3. Bioresorbable Stents
                     5.3.1.4. Others
            5.3.2. Peripheral Stents
                     5.3.2.1. Self-expanding Stents
                     5.3.2.2. Balloon-expanding Stents
                     5.3.2.3. Others
     5.4. Market Attractiveness By Product 
     5.5. Key Trends

6. Global Arterial Stents Market Analysis and Forecasts, By Application 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast By Application, 2015–2025
            6.3.1. Coronary Artery
            6.3.2. Carotid Artery
            6.3.3. Iliac Artery
            6.3.4. Femoral & Popliteal Artery
            6.3.5. Others
     6.4. Market Attractiveness By Application 
     6.5. Key Trends

7. Global Arterial Stents Market Analysis and Forecasts, By Region
     7.1. Key Findings
     7.2. Market Value Forecast By Region
            7.2.1. North America 
            7.2.2. Europe 
            7.2.3. Asia Pacific 
            7.2.4. Latin America 
            7.2.5. Middle East & Africa 
     7.3. Market Attractiveness By Country/Region

8. North America Arterial Stents Market Analysis and Forecast
     8.1. Introduction
            8.1.1. Key Findings
     8.2. Market Value Forecast By Product, 2015–2025
            8.2.1. Coronary Stents
                     8.2.1.1. Bare Metal Stents
                     8.2.1.2. Drug-eluting Stents
                     8.2.1.3. Bioresorbable Stents
                     8.2.1.4. Others
            8.2.2. Peripheral Stents
                     8.2.2.1. Self-expanding Stents
                     8.2.2.2. Balloon-expanding Stents
                     8.2.2.3. Others
     8.3. Market Value Forecast By Application, 2015–2025
            8.3.1. Coronary Artery
            8.3.2. Carotid Artery
            8.3.3. Iliac Artery
            8.3.4. Femoral & Popliteal Artery
            8.3.5. Others
     8.4. Market Value Forecast By Country, 2015–2025
            8.4.1. U.S.
            8.4.2. Canada
     8.5. Market Attractiveness Analysis 
            8.5.1. By Product 
            8.5.2. By Application 
            8.5.3. By Country
     8.6. Key trends

9. Europe Arterial Stents Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
     9.2. Market Value Forecast By Product, 2015–2025
            9.2.1. Coronary Stents
                     9.2.1.1. Bare Metal Stents
                     9.2.1.2. Drug-eluting Stents
                     9.2.1.3. Bioresorbable Stents
                     9.2.1.4. Others
            9.2.2. Peripheral Stents
                     9.2.2.1. Self-expanding Stents
                     9.2.2.2. Balloon-expanding Stents
                     9.2.2.3. Others
     9.3. Market Value Forecast By Application, 2015–2025
            9.3.1. Coronary Artery
            9.3.2. Carotid Artery
            9.3.3. Iliac Artery
            9.3.4. Femoral & Popliteal Artery
            9.3.5. Others
     9.4. Market Value Forecast By Country, 2015–2025
            9.4.1. Germany
            9.4.2. U.K.
            9.4.3. France
            9.4.4. Spain
            9.4.5. Italy
            9.4.6. Rest of Europe
     9.5. Market Attractiveness Analysis 
            9.5.1. By Product 
            9.5.2. By Application 
            9.5.3. By Country
     9.6. Key Trends

10. Asia Pacific Arterial Stents Market Analysis and Forecast
     10.1.Introduction
            10.1.1. Key Findings
     10.2.Market Value Forecast By Product, 2015–2025
            10.2.1. Coronary Stents
                     10.2.1.1. Bare Metal Stents
                     10.2.1.2. Drug-eluting Stents
                     10.2.1.3. Bioresorbable Stents
                     10.2.1.4. Others
            10.2.2. Peripheral Stents
                     10.2.2.1. Self-expanding Stents
                     10.2.2.2. Balloon-expanding Stents
                     10.2.2.3. Others
     10.3.Market Value Forecast By Application, 2015–2025
            10.3.1. Coronary Artery
            10.3.2. Carotid Artery
            10.3.3. Iliac Artery
            10.3.4. Femoral & Popliteal Artery
            10.3.5. Others
     10.4.Market Value Forecast By Country, 2015–2025
            10.4.1. China
            10.4.2. India
            10.4.3. Japan
            10.4.4. Rest of Asia Pacific
     10.5.Market Attractiveness Analysis 
            10.5.1. By Product 
            10.5.2. By Application 
            10.5.3. By Country
     10.6. Key Trends

11. Latin America Arterial Stents Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
     11.2.Market Value Forecast By Product, 2015–2025
            11.2.1. Coronary Stents
                     11.2.1.1. Bare Metal Stents
                     11.2.1.2. Drug-eluting Stents
                     11.2.1.3. Bioresorbable Stents
                     11.2.1.4. Others
            11.2.2. Peripheral Stents
                     11.2.2.1. Self-expanding Stents
                     11.2.2.2. Balloon-expanding Stents
                     11.2.2.3. Others
     11.3.Market Value Forecast By Application, 2015–2025
            11.3.1. Coronary Artery
            11.3.2. Carotid Artery
            11.3.3. Iliac Artery
            11.3.4. Femoral & Popliteal Artery
            11.3.5. Others
     11.4.Market Value Forecast By Country, 2015–2025
            11.4.1. Brazil
            11.4.2. Mexico
            11.4.3. Rest of Latin America
     11.5.Market Attractiveness Analysis 
            11.5.1. By Product 
            11.5.2. By Application 
            11.5.3. By Country
     11.6. Key Trends

12. Middle East & Africa Arterial Stents Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
     12.2.Market Value Forecast By Product, 2015–2025
            12.2.1. Coronary Stents
                     12.2.1.1. Bare Metal Stents
                     12.2.1.2. Drug-eluting Stents
                     12.2.1.3. Bioresorbable Stents
                     12.2.1.4. Others
            12.2.2. Peripheral Stents
                     12.2.2.1. Self-expanding Stents
                     12.2.2.2. Balloon-expanding Stents
                     12.2.2.3. Others
     12.3.Market Value Forecast By Application, 2015–2025
            12.3.1. Coronary Artery
            12.3.2. Carotid Artery
            12.3.3. Iliac Artery
            12.3.4. Femoral & Popliteal Artery
            12.3.5. Others
     12.4.Market Value Forecast By Country, 2015–2025
            12.4.1. GCC Countries
            12.4.2. South Africa
            12.4.3. Israel
            12.4.4. Rest of Middle East & Africa
     12.5.Market Attractiveness Analysis 
            12.5.1. By Product 
            12.5.2. By Application 
            12.5.3. By Country
     12.6. Key Trends

13. Competition Landscape
     13.1.Market Player – Competition Matrix (By Tier and Size of companies)
     13.2.Market Share Analysis By Company (2016)
     13.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            13.3.1. Abbott Vascular (Abbott Laboratories)
                     13.3.1.1. Overview
                     13.3.1.2.Financials
                     13.3.1.3.Recent Developments
                     13.3.1.4.SWOT Analysis
                     13.3.1.5.Strategic Overview
            13.3.2. Cordis Corporation (A Cardinal Health Company)
                     13.3.2.1. Overview
                     13.3.2.2.Financials
                     13.3.2.3.Recent Developments
                     13.3.2.4.SWOT Analysis
                     13.3.2.5.Strategic Overview
            13.3.3. Boston Scientific Corporation
                     13.3.3.1. Overview
                     13.3.3.2.Financials
                     13.3.3.3.Recent Developments
                     13.3.3.4.SWOT Analysis
                     13.3.3.5.Strategic Overview
            13.3.4. Medtronic 
                     13.3.4.1. Overview
                     13.3.4.2.Financials
                     13.3.4.3.Recent Developments
                     13.3.4.4.SWOT Analysis
                     13.3.4.5.Strategic Overview
            13.3.5. C. R. Bard, Inc. (BARD Peripheral Vascular)
                     13.3.5.1. Overview
                     13.3.5.2.Financials
                     13.3.5.3.Recent Developments
                     13.3.5.4.SWOT Analysis
                     13.3.5.5.Strategic Overview
            13.3.6. Biosensors International Group, Ltd.
                     13.3.6.1. Overview
                     13.3.6.2.Financials
                     13.3.6.3.Recent Developments
                     13.3.6.4.SWOT Analysis
                     13.3.6.5.Strategic Overview
            13.3.7. Lifetech Scientific
                     13.3.7.1. Overview
                     13.3.7.2.Financials
                     13.3.7.3.Recent Developments
                     13.3.7.4.SWOT Analysis
                     13.3.7.5.Strategic Overview
            13.3.8. BIOTRONIK AG
                     13.3.8.1. Overview
                     13.3.8.2.Financials
                     13.3.8.3.Recent Developments
                     13.3.8.4.SWOT Analysis
                     13.3.8.5.Strategic Overview
            13.3.9. Cook Medical
                     13.3.9.1. Overview
                     13.3.9.2.Financials
                     13.3.9.3.Recent Developments
                     13.3.9.4.SWOT Analysis
                     13.3.9.5.Strategic Overview
            13.3.10. W. L. Gore & Associates, Inc. 
                     13.3.10.1. Overview
                     13.3.10.2.Financials
                     13.3.10.3.Recent Developments
                     13.3.10.4.SWOT Analysis
                     13.3.10.5.Strategic Overview

List of Tables

Table 01 Product Mapping (Abbott Vascular)
Table 02 Product Mapping (Boston Scientific Corporation)
Table 03 Product Mapping (Biotronik AG, Meril Lifesciences, JOTEC GmbH)
Table 04 Product Mapping (Biosensors International, ENDOLOGIX, INC)
Table 05 Product Mapping (Cordis Corporation, Terumo Corporation)
Table 06 Product Mapping (Medtronic)
Table 07 Product Mapping (B. Braun Melsungen AG, Microport)
Table 08 Product Mapping (Vascular Concept)
Table 09 Product Mapping (Translumina GmBH, Lombard Medical, Scitech, Minvasys)
Table 10 Product Mapping (iVascular SLU, Elixir Medical Corporation, Andramed GmbH)
Table 11 Product Mapping (Endocor GmBH, Arthesys)
Table 12 Product Mapping (Eurocor GmbH, ORBUSNEICH, Hexacath)
Table 13 Product Mapping (Amaranth Medical, InSitu Technologies, Inc., Kyoto Medical)
Table 14 Product Mapping (Comed B. V.,  Alvimedica, Accura Medizintechnik GmbH, Micelle Technologies)
Table 15 Product Mapping (ELLA - CS, Cook Medical, Lepu Medical)
Table 16 Arterial Stents Average Selling Prices (US$), and Analysis, By Stent Type, 2016
Table 17 Global Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 18 Global Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 19 Global Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 20 Global Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 21 Global Arterial Stents Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 22 North America Arterial Stents Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23 North America Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 24 North America Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 25 North America Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 26 North America Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 27 Europe Arterial Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 28 Europe Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 29 Europe Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 30 Europe Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 31 Europe Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 32 Asia Pacific Arterial Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 33 Asia Pacific Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 34 Asia Pacific Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 35 Asia Pacific Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 36 Asia Pacific Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 37 Latin America Arterial Stents Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 38 Latin America Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 39 Latin America Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 40 Latin America Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 41 Latin America Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 42 Middle East & Africa Arterial Stents Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 43 Middle East & Africa Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 44 Middle East & Africa Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 45 Middle East & Africa Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 46 Middle East & Africa Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025

List of Figures

 

Fig. 01 Global Arterial Stents Market Size (US$ Mn) Forecast, 2015–2025

Fig. 02 Global Arterial Stents Market Value Share, by Product (2016)

Fig. 03 Global Arterial Stents Market Value Share, by Application (2016)

Fig. 04 Global Arterial Stents Market Value Share, by Region (2016)

Fig. 05 Global Prevalence of CAD, By Country, 2016

Fig. 06 Global Prevalence of CAD (%), By Age Group and Gender, 2015

Fig. 07 Global Prevalence of PAD (%), By Age Group and Gender, 2015

Fig. 08 Global Coronary Stents Volume Forecast (‘000), 2015–2025

Fig. 09 Global Peripheral Stents Volume Forecast (‘000), 2015–2025

Fig. 10 Global Arterial Stents Market Value Share, by Product, 2017 and 2025

Fig. 11 Global Arterial Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Coronary Stents, 2015–2025

Fig. 12 Global Arterial Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Peripheral Stents, 2015–2025

Fig. 13 Global Arterial Stents Market Attractiveness, by Product, 2017–2025

Fig. 14 Global Arterial Stents Market Value Share, by Application, 2017 and 2025

Fig. 15 Global Arterial Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Iliac Artery, 2015–2025

Fig. 16 Global Arterial Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Carotid Artery, 2015–2025

Fig. 17 Global Arterial Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Coronary Artery, 2015–2025

Fig. 18 Global Arterial Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Femoral & Popliteal Artery, 2015–2025

Fig. 19 Global Arterial Stents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025

Fig. 20 Global Arterial Stents Market Attractiveness, by Application, 2017–2025

Fig. 21 Global Arterial Stents Market Value Share, by Region, 2017 and 2025

Fig. 22 Global Arterial Stents Market Attractiveness, by Region, 2017–2025

Fig. 23 North America Arterial Stents Market Value Share, by Country, 2017 and 2025

Fig. 24 North America Arterial Stents Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025

Fig. 25 North America Arterial Stents Market Attractiveness, by Country, 2017–2025

Fig. 26 North America Arterial Stents Market Value Share, by Product, 2017 and 2025

Fig. 27 North America Arterial Stents Market Attractiveness, by Product, 2017–2025

Fig. 28 North America Arterial Stents Market Value Share, by Application, 2017 and 2025

Fig. 29 North America Arterial Stents Market Attractiveness, by Application, 2017–2025

Fig. 30 Europe Arterial Stents Market Value Share, by Country/Sub-region, 2017 and 2025

Fig. 31 Europe Arterial Stents Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025

Fig. 32 Europe Arterial Stents Market Attractiveness, by Country/Sub-region, 2017–2025

Fig. 33 Europe Arterial Stents Market Value Share, by Product, 2017 and 2025

Fig. 34 Europe Arterial Stents Market Attractiveness, by Product, 2017–2025

Fig. 35 Europe Arterial Stents Market Value Share, by Application, 2017 and 2025

Fig. 36 Europe Arterial Stents Market Attractiveness, by Application, 2017–2025

Fig. 37 Asia Pacific Arterial Stents Market Value Share, by Country/Sub-region, 2017 and 2025

Fig. 38 Asia Pacific Arterial Stents Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025

Fig. 39 Asia Pacific Arterial Stents Market Attractiveness, by Country/Sub-region, 2017–2025

Fig. 40 Asia Pacific Arterial Stents Market Value Share, by Product, 2017 and 2025

Fig. 41 Asia Pacific Arterial Stents Market Attractiveness, by Product, 2017–2025

Fig. 42 Asia Pacific Arterial Stents Market Value Share, by Application, 2017 and 2025

Fig. 43 Asia Pacific Arterial Stents Market Attractiveness, by Application, 2017–2025

Fig. 44 Latin America Arterial Stents Market Value Share, by Country, 2017 and 2025

Fig. 45 Latin America Arterial Stents Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025

Fig. 46 Latin America Arterial Stents Market Attractiveness, by Country, 2017–2025

Fig. 47 Latin America Arterial Stents Market Value Share, by Product, 2017 and 2025

Fig. 48 Latin America Arterial Stents Market Attractiveness, by Product, 2017–2025

Fig. 49 Latin America Arterial Stents Market Value Share, by Application, 2017 and 2025

Fig. 50 Latin America Arterial Stents Market Attractiveness, by Application, 2017–2025

Fig. 51 Middle East & Africa Arterial Stents Market Value Share, by Country, 2017 and 2025

Fig. 52 Middle East & Africa Arterial Stents Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025

Fig. 53 Middle East & Africa Arterial Stents Market Attractiveness, by Country, 2017–2025

Fig. 54 Middle East & Africa Arterial Stents Market Value Share, by Product, 2017 and 2025

Fig. 55 Middle East & Africa Arterial Stents Market Attractiveness, by Product, 2017–2025

Fig. 56 Middle East & Africa Arterial Stents Market Value Share, by Application, 2017 and 2025

Fig. 57 Middle East & Africa Arterial Stents Market Attractiveness, by Application, 2017–2025

Fig. 58 Global Arterial Stents Market Share, by Company, 2016

Fig. 59 Abbott Laboratories Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016

Fig. 60 Abbott Laboratories Breakdown of Net Sales (%), by Region, 2016

Fig. 61 Cardinal Health Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016

Fig. 62 Cardinal Health Breakdown of Net Sales (%), by Business Segment, 2016

Fig. 63 Medtronic Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016

Fig. 64 Medtronic Breakdown of Net Sales (%), by Region, 2016

Fig. 65 Boston Scientific Corporation Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016

Fig. 66 Boston Scientific Corporation Breakdown of Net Sales (%), by Region, 2016

Fig. 67 Lifetech Scientific Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016

Fig. 68 C. R. Bard, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016

Fig. 69 C. R. Bard, Inc. Breakdown of Net Sales (%), by Business Segment, 2016

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Arterial Stents Market